TFC Therapeutics
Transforming T cells into medicines
New York, United States · Founded 2022 · $100K raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- tfctx.com
- Total Funding
- $100K
- Last Round
- $100K SeedMar 2026
- Rounds
- 2
About
TFC Therapeutics is a clinical-stage biopharmaceutical company developing T-cell-based immunotherapies for cancer and autoimmune diseases, leveraging a proprietary TFC platform.
Summary
TFC Therapeutics is a Biotech company based in New York, United States, founded in 2022. It has raised $100K in total across 2 rounds, most recently a $100K Seed round in Mar 2026. Investors include Private Investors, ARCH Venture Partners and Alexandria Real Estate Equities.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...